Your browser doesn't support javascript.
loading
Revealing the structural and molecular interaction landscape of the favipiravir-RTP and SARS-CoV-2 RdRp complex through integrative bioinformatics: Insights for developing potent drugs targeting SARS-CoV-2 and other viruses.
Chakraborty, Chiranjib; Bhattacharya, Manojit; Saha, Abinit; Alshammari, Abdulrahman; Alharbi, Metab; Saikumar, G; Pal, Soumen; Dhama, Kuldeep; Lee, Sang-Soo.
  • Chakraborty C; Department of Biotechnology, School of Life Science and Biotechnology, Adamas University, Kolkata, West Bengal 700126, India. Electronic address: drchiranjib@yahoo.com.
  • Bhattacharya M; Department of Zoology, Fakir Mohan University, Vyasa Vihar, Balasore 756020, Odisha, India.
  • Saha A; Department of Biotechnology, School of Life Science and Biotechnology, Adamas University, Kolkata, West Bengal 700126, India.
  • Alshammari A; Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Post Box 2455, Riyadh 11451, Saudi Arabia.
  • Alharbi M; Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Post Box 2455, Riyadh 11451, Saudi Arabia.
  • Saikumar G; Division of Pathology, ICAR-Indian Veterinary Research Institute, Izatnagar, Bareilly 243122, Uttar Pradesh, India.
  • Pal S; School of Mechanical Engineering, Vellore Institute of Technology, Vellore 632014, Tamil Nadu, India.
  • Dhama K; Division of Pathology, ICAR-Indian Veterinary Research Institute, Izatnagar, Bareilly 243122, Uttar Pradesh, India.
  • Lee SS; Institute for Skeletal Aging & Orthopaedic Surgery, Hallym University-Chuncheon Sacred Heart Hospital, Chuncheon-si 24252, Gangwon-do, Republic of Korea.
J Infect Public Health ; 16(7): 1048-1056, 2023 Jul.
Article en En | MEDLINE | ID: mdl-37196368

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article